In vivo and Transgenic Models

Venue: Kempinski Hotel Bristol

Location: Berlin, Germany

Event Date/Time: Sep 16, 2004 End Date/Time: Sep 17, 2004
Report as Spam


Technological advances are transforming the field of in vivo transgenics, leading to improved optimisation and more effective target validation in drug discovery. Increasingly sophisticated production of customised, humanised, conditional models is rising to meet the needs of researchers in both academia and industry.
This C5 conference brings together the latest technologies and examples of models being utilised
and developed for screening and functional analyses. This highly focused and intensive conference will be examining how specific and complex in vivo modelling and transgenesis is being achieved with respect to knock-in/out, ENU mutagenesis, RNAi and lentiviruses in zebrafish and rodents. Experts in the field will discuss how they have developed these models and the future challenges to be met.
Attend this conference and hear from an impressive group of experts working in the field of in vivo and transgenics,

Hear latest developments in:
• RNAi in vivo
• Conditional/Inducible systems
• Systemic phenotyping
• Lentiviral transgenesis
• In vivo imaging
• Zebrafish in drug discovery

Includes speakers from: Aventis Pharma, Merck, Sharp & Dohme, AstraZeneca, MIT, Institute Pasteur, Cambridge University, and many other key industry players.

EF International has changed its name to C5 to reflect the consolidation of its 5 conference groups across 5 continents.